Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation

Lopes, Renato D., Heizer, Gretchen, Aronson, Ronald, Vora, Amit N., Massaro, Tyler, Mehran, Roxana, Goodman, Shaun G., Windecker, Stephan +14 more·2019·New England Journal of Medicine
DOI 10.1056/nejmoa1817083

Cited by (1,000)

Items 801–900 of 1,000

  1. Evaluating the potential of factor XI/factor XIa inhibitors to address unmet anticoagulation needs in critical patient populations
    Tzu‐Fei Wang, Melissa F. Glasner, Rasha Al-Lamee, María Cecilia Bahit, Jonathan M. Coutinho, David Gailani, S. Claiborne Johnston, Carolyn S.P. Lam, Wolfgang C. Winkelmayer­, Jeffrey Ian Weitz · 2026 · Research and Practice in Thrombosis and Haemostasis
  2. Percutaneous coronary intervention using sirolimus-eluting balloons in patients at high bleeding risk: the SELUTION DeNovo HBR substudy
    Tuomas T. Rissanen, Simon Eccleshall, Florian Krackhardt, Kris Bogaerts, Tanios Akiki, Carlo Briguori, Guillaume Cayla, Nick Cruden, Alexander W. den Hartog, Philippe Garot et al. · 2026 · EuroIntervention
  3. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention
    Jang‐Whan Bae · 2019 · Cardiovascular Prevention and Pharmacotherapy
  4. For Primary Prevention, Should All Moderate- to High-Risk Patients Be Considered Candidates for Acetylsalicylic Acid?
    Jennifer Bolt, Peter S Loewen · 2020 · The Canadian Journal of Hospital Pharmacy
  5. The year in review: coronary interventions
    Chao Gao, Rutao Wang, Faisal Sharif, Kuniaki Takahashi, Masafumi Ono, Hironori Hara, Mariusz Tomaniak, Hideyuki Kawashima, Rodrigo Modolo, Robert‐Jan van Geuns et al. · 2020 · EuroIntervention
  6. Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
    Tatiana M. Uskach, Andrew S. Tereshchenko · 2020 · Rational Pharmacotherapy in Cardiology
  7. In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry
    Fumiaki Yashima, Taku Inohara, Hiroaki Nishida, Kenichiro Shimoji, Koji Ueno, Shigetaka Noma, Kyohei Yamaji, Hideki Ishii, Nobuhiro Tanaka, Shun Kohsaka et al. · 2021 · Journal of Cardiovascular Pharmacology
  8. Prise en charge du syndrome coronaire aigu sans élévation du segment ST, nouveautés des recommandations ESC 2020
    Paul Guedeney, J.‐P. Collet, Patrick Ecollan, Gilles Montalescot · 2021 · Journal Européen des Urgences et de Réanimation
  9. CHA2DS2‐VASc impact on risk following percutaneous coronary intervention in atrial fibrillation
    Thomas Jensen, Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Morten Würtz, Jens Cosedis Nielsen, Lisette Okkels Jensen, Morten Madsen, Troels Thim, Steen Dalby Kristensen, Gregory Y.H. Lip et al. · 2021 · European Journal of Clinical Investigation
  10. Embolic Stroke in Setting of Iliac Vein Stenosis in an Avid Cyclist
    Nikita Chhabra, Benzion Blech, David F. Fortuin, Susan Wilansky, Bart M. Demaerschalk, Oana Dumitrașcu · 2022 · The Neurohospitalist
  11. The Efficacy of Low Dose Edoxaban for the Treatment of Venous Thromboembolism
    Yusuke Endo, Naoto Yamamoto, Nozomu Ishikawa, Hajime Tsuyuki, Yuta Yamanaka, Takafumi Kayama, Tatsuro Yata, Kazuto Katahashi, Masaki Sano, Kazunori Inuzuka et al. · 2022 · The Japanese Journal of Phlebology
  12. Acute coronary syndrome without persistent elevation of the ST segment: New recommendations
    Saša Hinić · 2022 · Galenika Medical Journal
  13. Antithrombotic Management of Atrial Fibrillation Patients Presenting with Coronary Artery Disease: A Consensus Document of the Chinese Society of Cardiology
    Tianyu Xu · 2021 · Cardiology Discovery
  14. Antithrombotische Therapie
    Hans Wille · 2022 · Springer eBooks
  15. A Cardiologists’ Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous Coronary Intervention in India
    Namrata Kulkarni, Santosh Ramesh Taur, Jaspreet Kaur, Ravishankar Akolekar, Swetha ES · 2023 · Cureus
  16. A Single-Center Bleeding Comparison of Warfarin Plus Aspirin or Clopidogrel Following Coronary Artery Bypass Grafting and Surgical Valve Replacement
    Joseph J Zieminski, Kristin C. Mara, Kyle S. Wamsley, John M. Stulak, Scott D. Nei · 2023 · Clinical and Applied Thrombosis/Hemostasis
  17. The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman
    Dalia Ahmed Al-Hadithy, Juhaina Salim Al-Maqbali, Adil B. Al-Riyami, Mohammed Al Za’abi, Ibrahim S Al-Zakwani · 2023 · Pharmacy
  18. Reporting quality of randomized controlled trials evaluating non-vitamin K oral anticoagulants in atrial fibrillation: a systematic review
    YueGuang Yang, YuBo Han, Guoliang Zou, Yan-Bo Sui, Juan Jin, Li Liu · 2023 · BMC Cardiovascular Disorders
  19. Clinical Use of Direct Oral Anticoagulants and Reversal: Consideration for Vascular Surgeons
    Alan M. Houben, Vincent Luce Bonhomme, Marc Sénard · 2023 · Journal of Vascular Diseases
  20. Protocol for systematic review and meta-analysis on randomized clinical trials for direct oral anticoagulant in subjects with acute coronary syndrome
    Israa Yousif Khidir, Asim Ahmed Elnour, Abdulla Al Amoodi, Abrar Ayad Alrashedi, Haifa Hamoud Almansour, Teif Abdulkarim Almarwani, Shahad Fayad Alrwili, Shahad Fayad Alrowaili, Shouq Lutfi Al Khudhairy, Asma Faisal Alshammari et al. · 2023 · Pharmacy Practice
  21. Comparison of Various Regimens of Antithrombotic Therapy in Patients With Valvular Heart Disease and Coronary Artery Disease After Surgical and Interventional Interventions
    Е.В. Рузина, Bektur Sh. Berdibekov, Naida I. Bulaeva, М.Ч. Кубова, Elena Zelikovna Golukhova · 2023 · Kardiologiia
  22. Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
    Stephan Ernst Baldus, Jan Beyer‐Westendorf, Helge Möllmann, Wolfgang Rottbauer, Elisabeth Beyerlein, Andreas Goette · 2023 · Scientific Reports
  23. Early in-hospital discontinuation of aspirin on the first post-procedural day after percutaneous coronary stent implantation in patients on direct oral anticoagulation
    Philipp von Stein, Lukas Seitz, Hendrik Wienemann, Christopher Hohmann, Till Baar, Stephan Ernst Baldus, Marcel Halbach · 2023 · Frontiers in Cardiovascular Medicine
  24. Safety and efficacy of NOAC vs. VKA in patients treated by PCI: a retrospective study of the FRANCE PCI registry
    Éric Durand, T. Verrez, André Gillibert, Thomas Lévesque, Thomas Barbe, René Köning, Pascal Motreff, Hélène Eltchaninoff, Jean‐Philippe Collet, Grégoire Rangé · 2024 · Frontiers in Cardiovascular Medicine
  25. Analysis of appropriateness and safety when discharging patients on triple-antithrombotic therapies
    Taylor P. Robichaux, Kristyn Edwards, Ashley Carter, Andrea Washington, Shelby P. Brooks · 2024 · American Journal of Health-System Pharmacy
  26. Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention
    Kaori Abe, Hideki Kitahara, Sakuramaru Suzuki, Takashi Hiraga, Tatsuro Yamazaki, Yuji Ohno, Junya Harada, Kenichi Fukushima, Tatsuhiko Asano, Naoki Ishio et al. · 2024 · International Journal of Cardiology
  27. Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48 hours
    Alexandre Salaun, Emmanuel de Maistre, Marlène Daller, Chan Sombrun, Frederic Chague, F. Bichât, Luc Rochette, Nicolas Danchin, Laurent Fauchier, Marianne Zeller et al. · 2024 · Archives of cardiovascular diseases
  28. Antithrombotische Therapie beim akuten Koronarsyndrom
    Andreas Schäfer · 2024 · DMW - Deutsche Medizinische Wochenschrift
  29. Role of anticoagulation in non-ST-elevation myocardial infarction: a contemporary narrative review
    Paul Jie Wen Tern, Khung Keong Yeo, Jack Wei Chieh Tan, Chee Tang Chin, Ru‐San Tan, Jonathan Jiunn Liang Yap · 2024 · Expert Review of Cardiovascular Therapy
  30. Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation
    Jihoon Kim, Danbee Kang, Hyunsoo Kim, Hye‐Jeong Park, Taek Kyu Park, Joo Myung Lee, Jeong Hoon Yang, Young Bin Song, Jin-Ho Choi, Seung‐Hyuk Choi et al. · 2024 · Journal of Korean Medical Science
  31. Dual vs triple antithrombotic therapy in atrial fibrillation and acute coronary syndrome: An updated meta-analysis of randomized controlled trials
    Enkhtsogt Sainbayar, Hoang Nhat Pham, April Olson, Ramzi Ibrahim, Harneet Grewal, Mohammed Salih, Mamas A. Mamas, Kwan Seung S Lee · 2024 · Journal of Investigative Medicine
  32. Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial
    Alexander C. Fanaroff, DANIEL M. WOJDYLA, Christopher Bull Granger, Shaun G. Goodman, RONALD S. ARONSON, Stephan Windecker, Roxana Mehran, John Hunter Alexander, Renato D. Lópes · 2024 · Circulation Cardiovascular Interventions
  33. COMORBIDITY AS A FACTOR OF GASTRODUODENAL ULCER DEVELOPMENT IN ELDERLY AND SENILE PATIENTS
    Сахабетдинова Камиля Наилевна, B. A. Sakhabetdinov, NAIL B. AMIROV · 2024 · The Bulletin of Contemporary Clinical Medicine
  34. Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment
    Haolong Han, Hang Xu, Jifan Zhang, Weihui Zhang, Yi Yang, Xia Wang, Li Wang, Dongjin Wang, Weihong Ge · 2025 · Frontiers in Pharmacology
  35. Safety and efficacy of edoxaban monotherapy after bioabsorbable polymer everolimus-eluting stent implantation in a human-like coronary atherosclerotic porcine model
    Daisuke Kitano, Suguru Migita, Yuxin Li, Yutaka Koyama, Katsunori Fukumoto, Sayaka Shimodai‐Yamada, Akira Ōnishi, Daiichiro Fuchimoto, Shunichi Suzuki, Yoshiyuki Nakamura et al. · 2025 · Atherosclerosis Plus
  36. Anticoagulation Therapy for Venous Thromboembolism
    Phillip Anjum, Alyssa E. Utz, Michael Kimbrell, Mikhail Y. Akbashev · 2025 · Medical Clinics of North America
  37. Clinical characteristics, therapeutic strategies, and outcomes in elderly patients on oral anticoagulant therapy undergoing percutaneous coronary interventions: post-hoc analysis of the PERSEO Registry
    Simona Minardi, Salvatore De Rosa, Nicolò Salvi, Giuseppe Andò, Giuseppe Talanas, Claudio D’angelo, Carolina Moretti, Tiziano Maria Mazza, Bernardo Cortese, Giuseppe Musumeci et al. · 2025 · 老年心脏病学杂志：英文版
  38. Orale Antikoagulation und antithrombozytäre Therapie bei Patienten mit Vorhofflimmern nach Koronarintervention
    Andreas Schäfer, Johann K Bauersachs · 2019 · Herz
  39. The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis
    Mohammed Osman, Babikir Kheiri, Muhammad Bilal Munir, Jason A. Moreland, Sudarshan Balla, Samir Ramesh Kapadia · 2019 · Journal of Thrombosis and Thrombolysis
  40. Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials
    Yi Wen Becky Liao, Tom Kai Ming Wang · 2019 · Coronary Artery Disease
  41. The Choice of Antithrombotic Therapy in a Patient with New-Onset Atrial Fibrillation and High Coronary Thrombotic risk.
    Gatto Maria Chiara, Lorena Cipollone, Galardo Gioacchino, Bresciani Emanuela, Alessandroni Maria, Massimo Mancone, Lavalle Carlo, Pugliese Francesco, Francesco Fedele · 2019 · Journal of Atrial Fibrillation
  42. Appropriate cohort selection and its impact on a meta-analysis evaluating the efficacy of direct oral anticoagulants post-percutaneous coronary intervention
    Pradyumna Agasthi, Andrew S. Tseng, Siva K. Mulpuru · 2020 · European Heart Journal
  43. Cardiology and Therapy: A Summary of 2019 and Key Areas of Emerging Research in 2020
    Ian B A Menown, Robert Patrick Giugliano, Uwe Zeymer · 2020 · Cardiology and Therapy
  44. Beyond anticoagulant therapy. The not benign impact of atrial fibrillation on patients’ outcomes in a real world ‘scenario’
    Stefano Fumagalli · 2020 · European Journal of Internal Medicine
  45. O Tratamento Antiplaquetário por Via Oral na Doença Arterial Coronária – Visão Atual
    Gílson Soares Feitosa, Gilson Soares Feitosa-Filho, Paulo Barbosa, Rosenbert Da Silva, Thiago Vicente Pereira, Isabela Pilar Moraes Alves de Souza, Marcus Vinícius Santos Andrade, Antônio Carlos Sales Nery · 2020 · Revista Científica Hospital Santa Izabel
  46. The year in review: advances in interventional cardiology in 2019
    Keyvan Karimi Galougahi, Gregory Petrossian, Gregg W. Stone, Ziad A. Ali · 2020 · Current Opinion in Cardiology
  47. Uso em Longo Prazo de Anticoagulantes Orais na Cardiologia
    Renata Martins Almeida, Gílson Soares Feitosa · 2020 · Revista Científica Hospital Santa Izabel
  48. Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention
    Samer Al Said, Hugo Albert Katus, Samer Alabed · 2020 · Heart
  49. The role of clopidogrel in the current treatment of acute coronary syndrome
    I. S. Yavelov · 2020 · Aterotromboz = Atherothrombosis
  50. Impacto del tratamiento antitrombótico y los síndromes geriátricos en octogenarios con fibrilación auricular y cardiopatía isquémica. Fibrilación Auricular y Cardiopatía Isquémica en Longevos (FACIL)
    Clara Bonanad Lozano, Pablo Díez‐Villanueva, Sergio García‐Blas, Ana Ayesta, Sònia Ibars, Albert Ariza‐Solé, José Luis Ferreiro, Raúl Moreno, Inmaculada Roldán, Francisco R. Marín et al. · 2020 · Revista Española de Geriatría y Gerontología
  51. Ticagrelor in the Management of Coronary Artery Disease
    Krithika Loganath, Philip D Adamson, Alastair James Moss · 2020 · Future Cardiology
  52. Evolving Concepts in Post-PCI Antiplatelets Therapy
    Kartik Pandurang Jadhav, Pankaj Vinod Jariwala · 2020 · Indian Journal of Clinical Cardiology
  53. The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation
    Olga O. Shakhmatova · 2020 · Aterotromboz = Atherothrombosis
  54. Anticoagulantes nas síndromes coronarianas agudas: uma revisão sistemática
    Irineu Lopes de Alcântara Júnior, Angelo Bruno Pagoto, Ingrid Loureiro de Queiroz Lima, Tayrel dos Anjos Silva, Márcio Jadson Marialva Eliziário, Bárbara Aparecida de Souza e Souza, Armando Hiroyuki Mori Júnior, Bárbara Pires Ihara, Irilane de Alcântara Figueira, Ismael Henrique Azevedo de Alcântara · 2021 · Revista Eletrônica Acervo Saúde
  55. Rastreio e prevenção dos efeitos cardiotóxicos no tratamento do Câncer de Mama
    Ricardo Bolsson Radins, Leticia Bolsson Radins · 2021 · Editora Poisson eBooks
  56. ST-segment elevation myocardial infarction
    Borja Ibáñez, Stefan Karl James · 2021 · Oxford University Press eBooks
  57. Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation
    Rajeev K. Anchan, Adam S. Cifu, Jonathan Paul · 2021 · JAMA
  58. A Cautionary Tale of Triple Therapy
    Negeen Shahandeh, Jeffrey Harrell, Eric H. Yang, Rushi V. Parikh · 2021 · JACC Case Reports
  59. NSTE-ACS: Medikamentöse Therapie – Antithrombotische Therapie
    Konstantinos D. Rizas, Dirk Sibbing · 2021 · Aktuelle Kardiologie
  60. What antithrombotic therapy should I use for my patient with atrial fibrillation who underwent percutaneous coronary intervention or had an acute coronary syndrome?
    Andrew S. Tseng, Fadi Elias Shamoun, Lisa A. Marks, Neera Agrwal · 2021 · Cleveland Clinic Journal of Medicine
  61. Post PCI severe gastrointestinal bleeding in the setting of idiopathic thrombocytopenic purpura: a treatment dilemma
    Hafiz U Ghafoor, Nitish Kumar Sharma, Sai Vikram Alampoondi Venkataramanan, Michelle L. Hadley · 2021 · BMJ Case Reports
  62. Direct Oral Anticoagulants and Left Ventricular Thrombosis: The Evidence for a Good Therapeutic Approach
    Mauro Massussi, Andrea Scotti, Antonio Landi, George Besis · 2021 · Springer eBooks
  63. Review of the top 5 cardiology studies of 2019-20
    Arden R. Barry, Hazal E. Babadagli, Rosaleen Boswell, June W. Chen, Ellen L. Dawson, David G. Lopaschuk, Chloe L. McMillan, Binh V. Nguyen, Mohamed A. Omar, Dylan M. Pollmann et al. · 2021 · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
  64. New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention
    Sabato Sorrentino, Nadia Salerno, Isabella Leo, Alberto Polimeni, Jolanda Sabatino, Carmen Spaccarotella, Annalisa Mongiardo, Salvatore De Rosa, Ciro Indolfi · 2021 · Current Vascular Pharmacology
  65. Dosage of direct oral anticoagulants during dual and triple antithrombotic therapy: a focus on the net clinical benefit
    Niema Kazem, Patrick Sulzgruber, Alexander Niessner · 2021 · European Heart Journal - Cardiovascular Pharmacotherapy
  66. Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    A. V. Panov · 2021 · Rational Pharmacotherapy in Cardiology
  67. Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial
    Marat Fudim, Daniel M. Wojdyla, John Hunter Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker, Ronald Aronson, Dragos Vinereanu, Sigrun Halvorsen, M. Cecilia Bahit et al. · 2021 · Journal of the American Heart Association
  68. Acute cerebral circulation impairment associated with percutaneous coronary intervention
    B. S. Sukovatykh, N. V. Bolomatov, D. V. Sidorov, M. B. Sukovatykh · 2021 · Angiology and vascular surgery
  69. Estrategias de antiagregación plaquetaria en síndromes coronarios agudos
    Juan Pablo Costabel, Ernesto Duronto, Sebastian Nani, Hernán Cohen Arazi, Javier Norberto Guetta · 2021 · Revista Argentina de Cardiología
  70. Use of Non-Vitamin K Dependent Oral Anticoagulant in Ischemic Stroke
    Hyungjong Park, Joonsang Yoo · 2022 · Journal of the Korean Neurological Association
  71. Triple antithrombotic therapy and dual therapy – What is the evidence base?
    Hani Essa, Rajiv Sankaranarayanan, Lauren E. Walker · 2022 · British Journal of Clinical Pharmacology
  72. Approche pratique à la prescription des antiplaquettaires chez les patients atteints de syndromes coronariens
    Mohammad Alkhalil, Michał Kuzemczak, Alan Bell, Sol Stern, Michelle Welsford, Warren J. Cantor, Shaun G. Goodman · 2022 · Canadian Medical Association Journal
  73. Discontinuation of antiplatelet and anticoagulant therapy before surgery
    А Ф Харазов, Naida Minatullaevna Basirova, ALEXANDER MARKOV · 2022 · Clinical and Experimental Surgery Petrovsky journal
  74. Present Use of Aspirin as an Antithrombotic Agent: Current or Outdated Drug?
    Alan Sigal, Fernando Belcastro, Juan Furmento, Daiana Dossi, Gustavo Hernán Cerezo, Marcelo Trivi, Juan Pablo Costabel · 2022 · Revista Argentina de Cardiología
  75. III CardioMIR: el Congreso de los Jóvenes Cardiólogos
    Pedro Luis Cepas Guillén, Ana Elvira Laffond, Cristina Lozano Granero, María Thiscal López Lluva · 2022 · REC CardioClinics
  76. Spontaneous Duodenal Hematoma: A Rare Complication of Triple Antithrombotic Therapy Case Report
    Mazin N Habhab, Asad J. Torabi, Julie M. Clary, George E. Revtyak · 2023 · Future Cardiology
  77. Direct Oral Anticoagulants use in Patients with Stable Coronary Artery Disease, Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
    Μarios Sagris, Panagiotis Theofilis, Angelos Papanikolaou, Alexios S. Antonopoulos, Constantinos Tsioufis, Dimitris Tousoulis · 2023 · Current Pharmaceutical Design
  78. DESCOBERTAS RELEVANTES SOBRE À SÍNDROME CORONARIANA AGUDA (SCA) E RELACIONADAS À OCORRÊNCIA DO INFARTO DO MIOCÁRDIO SEM ELEVAÇÃO DO SEGMENTO ST (IAMSSST)
    Alectsandro Carlos Fernandes de Oliveira, Antonione Lamartini Silva, Gabriel Mostaro Fonseca, José Maria Dias de Azeredo Bastos, Marco Antônio Ferreira dos Anjos, Maycon Fonseca Ramos, Paulo Roberto Ramos Alves, Samira Uziel · 2024 · EPITAYA eBooks
  79. Critical appraisal of the AUGUSTUS trial
    Thomas Gremmel, Patrick Sulzgruber, Alexander Niessner · 2019 · European Heart Journal - Cardiovascular Pharmacotherapy
  80. 1 vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention—Reply
    Hirotoshi Watanabe, Takeshi Kimura · 2019 · JAMA
  81. From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
    Andrea Rubboli, Elena Barbaresi, Bianca Rocca · 2019 · Cardiovascular Drugs and Therapy
  82. Clinical Considerations Prior to Transition From Triple Antithrombotic Therapy to Dual Antithrombotic Therapy—Reply
    Ralf E. Harskamp, John Hunter Alexander, Renato D. Lópes · 2019 · JAMA Cardiology
  83. To drop or not to drop the antiplatelet agent, that is the question for patients with atrial fibrillation and chronic coronary syndrome undergoing percutaneous coronary intervention
    Yongcheol Kim, Tom Johnson, Young‐Hoon Jeong · 2020 · Cardiology Journal
  84. Double vs. triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: does clinical presentation matter?
    Andrea Rubboli, Jean‐Philippe Collet · 2020 · European Heart Journal - Cardiovascular Pharmacotherapy
  85. Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
    Menno Volkert Huisman · 2021 · Netherlands Heart Journal
  86. Spoiled for Choice
    Dirk Sibbing, Steffen Maßberg, Konstantinos D. Rizas · 2024 · JACC: Cardiovascular Interventions
  87. Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Eunice Yang, Deepak L. Bhatt, Brett D. Atwater · 2024 · Journal of the American College of Cardiology
  88. OPTIMA-AF: Adding Fuel to the Fire Towards Minimal Combined Antithrombotic Regimens
    Alberto Alperi, Paula Antuña, Juan Rondan, Pablo Avanzas y · 2026 · European Cardiology Review
  89. Selección de lo mejor del año 2018 en riesgo vascular y rehabilitación cardiaca
    Pablo Toledo Frías, Raquel Campuzano Ruíz, José Antonio Alarcón Duque, Alejandro Berenguel Senén, María Rosa Fernández Olmo, Manuel Abeytua Jiménez · 2019 · REC CardioClinics
  90. Tailoring antithrombotic strategies for high-risk AF populations
    Irene Fernández-Ruíz · 2019 · Nature Reviews Cardiology
  91. Cardiology update - The first quarter
    Satyavir Yadav, Faraz Ahmed Farooqui, Swati Singh · 2019 · Journal of the Practice of Cardiovascular Sciences
  92. ULISSE – Facilitating the odyssey toward individualized DAPT
    Syed Zamin, Robert Jay Widmer · 2019 · International Journal of Cardiology
  93. Highlights from the 2019 American College of Cardiology Scientific Sessions in New Orleans, LA
    Dylan L Steen · 2019 · Journal of Thrombosis and Thrombolysis
  94. Acute coronary syndrome: STEMI and NSTEMI
    Abhiram Prasad, Claire E. Raphael · 2019 · Oxford University Press eBooks
  95. Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
    Tuomas Kiviniemi · 2019 · The American Journal of the Medical Sciences
  96. Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?
    Kartik Gupta, Shane P. Prejean, Muthiah Vaduganathan, Harsh B. Golwala, Thomas Evans Watts, Sudeep Raj Aryal, Gregory Von Mering, Oscar Julian Booker, Mustafa I. Ahmed, Navkaranbir Singh Bajaj · 2019 · IJC Heart & Vasculature
  97. Safe and Efficacious Use of 1-Month Triple Therapy in Patients with Atrial Fibrillation and High Bleeding Risk Undergoing PCI
    Antonia Sambola, Héctor Bueno, Berta Miranda, Adrián Vladimir Hernández, Javier Limeres Freire, Bruno García del Blanco, David García‐Dorado · 2019 · Cardiovascular Drugs and Therapy
  98. Triple Antithrombotic Therapy – Is It History or Should We Still Do It?
    Diana Opincariu · 2019 · Journal of Interdisciplinary Medicine
  99. Tratamiento antitrombótico doble frente a triple
    Leslie Marisol Lugo‐Gavidia, José Luis Ferreiro · 2019 · Revista Española de Cardiología Suplementos
  100. Atrial Fibrillation and Coronary Stenting: is the AUGUSTUS Trial the End of Triple therapy?
    Bastiaan Zwart, Jurriën M. ten Berg · 2019 · Future Cardiology